Leaders A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG
暂无分享,去创建一个
E. Berns | I. Vergote | S. Henzen‐Logmans | J. Paul | Diest | John A. Green | Peter | van | Dam | L. Mariae | D. Burg | J. Paul
[1] J. V. van Lanschot,et al. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation , 1998, The Journal of pathology.
[2] P. V. van Diest,et al. Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. , 1997, Blood.
[3] P. V. van Diest,et al. Reproducibility of subjective immunoscoring of steroid receptors in breast cancer. , 1996, Analytical and quantitative cytology and histology.
[4] B. Angus,et al. RETINOBLASTOMA PROTEIN IN HUMAN BREAST CARCINOMA: IMMUNOHISTOCHEMICAL STUDY USING A NEW MONOCLONAL ANTIBODY EFFECTIVE ON ROUTINELY PROCESSED TISSUES , 1996, The Journal of pathology.
[5] D. Henson,et al. Loss of p53-immunostaining intensity in breast cancer. , 1996, Journal of the National Cancer Institute.
[6] S. Schnitt,et al. Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. , 1996, Journal of the National Cancer Institute.
[7] F. Sarkar,et al. Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8] H. Multhaupt,et al. Quantitation in immunohistochemistry. A research method or a diagnostic tool in surgical pathology? , 1995, Pathologica.
[9] E. Kay,et al. C-erbB-2 immunostaining: problems with interpretation. , 1994, Journal of clinical pathology.
[10] P. V. van Diest,et al. Systematic random sampling for selective interactive nuclear morphometry in breast cancer sections. Refinement and multiobserver evaluation. , 1993, Analytical and quantitative cytology and histology.
[11] F T Bosman,et al. Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. , 1992, Journal of clinical pathology.
[12] P. V. van Diest,et al. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[13] P. V. van Diest,et al. Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[14] R. Hawkins,et al. RELATION BETWEEN IMMUNOCYTOCHEMICAL ESTIMATION OF OESTROGEN RECEPTOR IN ELDERLY PATIENTS WITH PRIMARY BREAST CANCER AND RESPONSE TO TAMOXIFEN , 1989, The Lancet.
[15] T. Lister,et al. The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma , 1988, The Journal of pathology.
[16] R. Østerby,et al. Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!‘ , 1981, Journal of microscopy.